Skip to main content
. 2020 May 21;7:182. doi: 10.3389/fmed.2020.00182

Figure 2.

Figure 2

The overall survival curves according to LGALS3 expression. (A) All the glioma cases of WHO I-IV, (B) WHO I PA, (C) WHO II-III LGG, (D) WHO IV GBM, (E) WHO III anaplastic astrocytoma, and (F) WHO II-IV IDH wildtype glioma. LGALS3-positive patients presented with significantly shorter OS than those of negative patients in all the gliomas, LGG, GBM, AA, and IDH glioma but no statistical difference in PA. PA, pilocytic astrocytoma; LGG, lower grade glioma; GBM, glioblastoma; AA, anaplastic astrocytoma.